Last updated on June 2018

A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)


Brief description of study

M2951 is an investigational drug under evaluation for treatment of autoimmune and inflammatory disorders. The purpose of the study is to assess the Safety and Efficacy of M2951 in Subjects with Systemic Lupus Erythematosus (SLE)

Clinical Study Identifier: NCT02975336

Contact Investigators or Research Sites near you

Start Over

Alberto Jorge Spindler

Centro Medico Privado de Reumatologia
San Miguel de Tucuman, Argentina
  Connect »

Veronica Ines Bellomio

Investigaciones Clinicas Tucuman
San Miguel de Tucuman, Argentina
  Connect »

Dora Lia Vasquez

Centro Integral de Reumatologia
San Miguel de Tucumán, Argentina
  Connect »